GL1X · GenesisL1 explorer

MolNFT v1 · #76658 · protein

The crystal structure of human ABL1 kinase domain T315I mutant in complex with dcc-2036

3QRJ · Tyrosine-protein kinase ABL1: “The crystal structure of human ABL1 kinase domain T315I mutant in complex with dcc-2036”. X-ray diffraction, 1 ligand (919), 7 pockets (best druggability 0.81). MolNFT v1 #76658 on GenesisL1: 3D…

PDB
3QRJ
Type
protein
Length
523 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase ABL1
EC
2.7.10.2
UniProt
P00519
Ligands
919
Pockets
7 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase ABL1 (EC 2.7.10.2)protein25843% helix, 17% strandP00519
BTyrosine-protein kinase ABL1 (EC 2.7.10.2)protein26543% helix, 17% strandP00519

Ligands and binding sites

  • 919 · 4-[4-({[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19630.810.82108919
25010.650.7740empty
3830.490.8216empty
4710.480.8315empty
5840.380.7721empty

Interfaces

1 interface between chains.

  • A–B · 289 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 3QRJ · The crystal structure of human abl1 kinase domain T315I mutant in complex with DCC-2036 · the same entry in another collection · chain A against A, TM-score 1.00
  • P00519 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase ABL1 (P00519) · a predicted model of the same protein · chain A against A, TM-score 0.91

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.